Skip to main content
. 2023 May 5;2023(5):CD002011. doi: 10.1002/14651858.CD002011.pub3

Gaskin 1998.

Study characteristics
Methods Single‐centre (Toronto, Canada) prospective parallel design RCT
66 participants (with CF attending adult and paediatric clinics) were "randomly assigned" to standard PD and percussion (CCPT) or PEP mask therapy (Astra Meditec) for 2 years.
Participants 66 participants, 61 participants completed.
Mean age 21.6 (SD 8.3) at enrolment; age range 11–45 years
34 males, 32 females
CCPT: mean age 21.9 (SD 8.7) years
PEP: mean age 21.3 (SD 8.0) years
Interventions CCPT
PEP
No indication of frequency or duration of, or adherence with each prescription.
Outcomes Followed up every 3 months for 2 years: FVC, FEV1, QoL (Quality of Well Being score), Brasfield CXR score, exercise testing (cycle ergometry). Compliance and exercise diaries kept by participants.
Notes Study reported in 1 abstract from 12th NACF conference (Gaskin 1998). Jadad score: 2/5.
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk Not reported: (quote) "patients were randomly assigned". Numbers assigned to each group not reported.
Allocation concealment (selection bias) Unclear risk Not described.
Blinding of participants and personnel (performance bias)
All outcomes Unclear risk Not feasible (participants), not described (personnel).
Blinding of outcome assessment (detection bias)
All outcomes Unclear risk Not described.
Incomplete outcome data (attrition bias)
All outcomes Unclear risk 5 participants (gender not reported) withdrew from study (0 lost to follow‐up): 4 withdrew from CCPT group immediately after randomisation; 1 from PEP group moved away.
Selective reporting (reporting bias) High risk Only baseline FEV1 and rate of decline trajectory provided. Secondary analysis of FEV1 data included only those aged < 19 years (unclear how many) and those compliant with treatments (unclear how many). No other outcome data reported – FVC, CXR score, QoL and exercise test results were absent. Compliance data not reported.
Other bias High risk Analysis with or without the withdrawn and non‐compliant participants in secondary analysis did not change the conclusions of the study. Numbers of non‐compliant participants were not reported. Conclusions that PEP was "valid alternative" to CPT not supported by results reported.